Here is the piece I published on Politico with the former majority leader about what we’ve learned about biopreparedness and how far we have to go.
A new process for producing pluripotent stem cells is both scientifically and ethically challenging.
Xconomy’s mission is “providing business and technology leaders with timely, insightful, close-to-the-scene information about the local personalities, companies, and technological trends that best exemplify today’s high-tech economy”. Link is here.
Listen to the podcast of my interview with Molly Moss-Koane here.
My Slate piece might disappoint some neurotech enthusiasts, and might prompt some responses, especially from industry. But I do think it’s important to keep some perspective on what neuroscience offers in the real world of national security.
This writer notes Penn’s strength in progressive bioethics, especially with the addition of Zeke Emanuel.
If you’ve worked on a book for a few years and poured your soul into it there’s nothing quite so validating as those first reviews. The fact that they are “pre-publication” and anonymous (so no kissing up, posturing, etc.), makes it even sweeter. And in all these cases the reviewers did their jobs seriously and had smart things to say about it. Did I mention that they were all favorable?
Library Journal review: “This is a sophisticated, useful, and
well-written guide to the history and complex political issues surrounding
the new biology. Recommended for anyone, general and scholarly readers
alike, interested in a deeper understanding of the new biology, bioethics,
and the political debates they engender.” August 15, 2011
Here’s my post on Science Progress about the phony vaccination campaign in the runup to the killing of Bin Laden. Though public health experts were understandably worried about the implications for future public health campaigns, I think the bigger story is what this says about the future of DNA collection for national security.